Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Zimmer NexGen Knee Lawsuits to be Selected for First Case Picks in MDL January 28, 2014 Irvin Jackson Add Your Comments Following a status conference held earlier this month in the federal multidistrict litigation (MDL) established for all Zimmer NexGen knee replacement lawsuits, the parties have been directed to submit their case picks for the first trial dates by February 7, 2014. There are currently nearly 1,200 product liability lawsuits filed in U.S. District Courts throughout the country that have been consolidated for pretrial proceedings before U.S. District Judge Rebecca R. Pallmeyer in the Northern District of Illinois, where a small group of cases are being prepared for early trial dates, known as “bellwether” cases. Pursuant to a prior case management order issued last year, which outlined the process for preparing the first Zimmer NexGen knee cases for a series of test trials, case-specific discovery has been on-going over the past six months. Stay Up-to-Date About Knee Replacement Lawsuits AboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits and warnings that may impact your family, which will include any new knee replacement lawsuit updates or developments. "*" indicates required fields Email* SIGN ME UP Δ Learn More Stay Up-to-Date About Knee Replacement Lawsuits AboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits and warnings that may impact your family, which will include any new knee replacement lawsuit updates or developments. "*" indicates required fields Email* SIGN ME UP Δ Learn More According to the minutes (PDF) from a status conference held before Judge Pallmeyer on January 17, the parties have been ordered to submit their recommended “case pool picks” by February 7, with each side filing a response to the selections by February 28, 2014. The next status conference in the Zimmer NexGen MDL is scheduled for March 21, 2014, with additional conference dates set through the remainder of the year for May 16, July 18, September 19 and November 21, 2014. Judge Pallmeyer previously indicated that the first cases will be trial ready by January 2015. The preparation and outcome of these early trial dates are designed to help the parties gauge how juries are likely to respond to certain evidence and testimony that may be repeated throughout the litigation. All of the complaints involve similar allegations that certain configurations of the Zimmer NexGen artificial knee system are defective and prone to fail within a few years. Plaintiffs claim that they experienced problems with various Zimmer knee replacements, including the Zimmer NexGen LPS-Flex, Zimmer NexGen CR-Flex, Zimmer NexGen GSF LPS-Flex, Zimmer NexGen GSF CR-Flex and Zimmer NexGen MIS Tibia component. Following the bellwether trials in the MDL, if a Zimmer NexGen knee settlement agreement or other resolution for the litigation is not reached, hundreds of cases could be remanded back to U.S. District Courts throughout the country for individual trial dates. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Knee Replacement System, Zimmer, Zimmer Knee Replacement, Zimmer NexGen More Zimmer NexGen Lawsuit Stories Zimmer NexGen Knee Replacement Bellwether Trial Ends in Defense Verdict November 9, 2015 Zimmer NexGen Knee Cases Selected for Bellwether Trials in 2015 March 28, 2014 Coordination Sought for Zimmer NexGen Knee Cases in Federal, State Cts March 14, 2014 1 Comments Sarah F January 13, 2017 I had a recalled knee revision I was with Anapol and Schwartz. my 1st knee 2009 I was told in beginning I met all requirements. My case was declined because a Dr wrote posible infection , no positive pathology. I after this time suffer so much my life is terrible as result. Don’t I have any alternative Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermFacebookThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Wayfair Fire Pit Lawsuit Links Flame Jetting Explosion to Defective Design (Posted: 3 days ago) In March 2026, a jury is scheduled to hear a Wayfair fire pit lawsuit from a woman who suffered burns to nearly half her body. MORE ABOUT: TABLETOP FIRE PIT LAWSUITAmazon Tabletop Fire Pit Lawsuit Alleges ‘Flame-Jetting’ Caused Third Degree Burns (08/29/2025)Tabletop Fire Pit Burn Victims Share Stories of Explosions and Devastating Injuries (08/21/2025)Colsen Fire Pit Lawsuit Involving Severe Burn Injuries Suffered by a Child Set for Trial Next Year (08/14/2025) Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (Posted: 4 days ago) Dupixent lawsuits are now being investigated after studies and FDA reports link Dupixent (dupilumab) to cutaneous T-cell lymphoma (CTCL). MORE ABOUT: DUPIXENT LAWSUITDupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025) Depo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (Posted: 5 days ago) A new study appears to further confirm and quantify the risks of Depo-Provera meningioma side effects, potentially providing further evidence for growing litigation. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025)Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (08/25/2025)Experts Weigh In On Depo-Provera Brain Tumor Risks, As Lawsuits Continue to Mount (08/20/2025)
Wayfair Fire Pit Lawsuit Links Flame Jetting Explosion to Defective Design (Posted: 3 days ago) In March 2026, a jury is scheduled to hear a Wayfair fire pit lawsuit from a woman who suffered burns to nearly half her body. MORE ABOUT: TABLETOP FIRE PIT LAWSUITAmazon Tabletop Fire Pit Lawsuit Alleges ‘Flame-Jetting’ Caused Third Degree Burns (08/29/2025)Tabletop Fire Pit Burn Victims Share Stories of Explosions and Devastating Injuries (08/21/2025)Colsen Fire Pit Lawsuit Involving Severe Burn Injuries Suffered by a Child Set for Trial Next Year (08/14/2025)
Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (Posted: 4 days ago) Dupixent lawsuits are now being investigated after studies and FDA reports link Dupixent (dupilumab) to cutaneous T-cell lymphoma (CTCL). MORE ABOUT: DUPIXENT LAWSUITDupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025)
Depo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (Posted: 5 days ago) A new study appears to further confirm and quantify the risks of Depo-Provera meningioma side effects, potentially providing further evidence for growing litigation. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025)Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (08/25/2025)Experts Weigh In On Depo-Provera Brain Tumor Risks, As Lawsuits Continue to Mount (08/20/2025)